A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study.

Open Access Rheumatol · 2009 · PMC5074716 · PMID 27789978

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

We also tested whether the inhibition of PI3K pathway would modulate the level of PAI-1 by using an inhibitor LY294002 (Cayman Chemical Co, Ann Arbor, MI); however the effect of LY294002 varied among tested chondrocyte samples and the results did not reach statistical significance to conclude the involvement of PI3K pathway (data not shown).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

A suppressive effect of prostaglandin E<sub>2</sub> on the expression of <i>SERPINE1</i>/plasminogen activator inhibitor-1 in human articular chondrocytes: An <i>in vitro</i> pilot study.

The sentences